Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03033550 · ClinicalTrials.gov registry record · NA
Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03033550 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT03033550, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a mobile health educational intervention for Human PapillomaVirus (HPV) Vaccination promotion and cervical cancer screening in Primary Care settings is a feasible behavioral intervention to integrate as a primary and secondary cervical cancer prevention approach.Study Design: The investigators will conduct an open feasibility proof-of-concept trial using a single experimental group with all subjects receiving the behavioral intervention being studied. Outcome measures. The primary outcome of interest is receipt of the first dose and completion of the three-dose series of HPV vaccine within 6 month of intervention, this will be evaluated by Electronic medical review review.
Interventions
- BEHAVIORAL brief negotiated mobile application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2018-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03033550
The ClinicalTrials.gov registry entry for NCT03033550 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which brief negotiated mobile application is the first listed.
NCT03033550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03033550 about?
NCT03033550 is a clinical study titled "Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings". The purpose of this study is to determine whether a mobile health educational intervention for Human PapillomaVirus (HPV) Vaccination promotion and cervical cancer screening in Primary Care settings is a feasible behavioral intervention to integrate as a primary and secondary cervical cancer prevent...
What is the current status of trial NCT03033550?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-05-08. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT03033550?
The interventions under investigation include: brief negotiated mobile application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03033550?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.